Despite only one in 12.5 million people wanting to buy male-enhancement products by clicking on a link in their junk mail, spammers are still making a profit, so a recent research paper claims.
Researchers at the University of California carried out a study on spam email and found that for one email advertising pharmaceuticals (specifically male-enhancement products (what else)) they got a conversion rate of 0.0000081%. That is 28 conversions out of 347,590,389 targeted emails addresses. Despite such a miniscule conversion rate, researchers claim they would have generated $2,731 in revenue.
The stats around spam are staggering. The BBC report that more than 90% of all email is spam, and there are only 200 spammers worldwide responsible for 80% of all spam. Apparently, most of these are in China or Russia.
According to the research, it is people in India, Pakistan and Bulgaria that are clicking on the “pharmaceuticals†spam the most – read into that what you will.
November 12, 2008
social media